Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00726830 · ADVERSE EVENTS

Adverse events

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer · Source last updated 2020-09-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
9 Months
Other-event reporting threshold
5%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Arm I: Opioid Rotation to Oral Methadone

Participants are switched from their current opioid medication (oxycodone or morphine) to methadone. Participants receive oral methadone 2-3 times daily for 4 weeks.

0 / 10 / 1Not reported / Not reported
Arm II: Opioid Rotation to Another Long-acting Strong Opioid

Participants currently receiving oxycodone are switched to sustained-release (SR) morphine. Participants currently receiving morphine are switched to SR oxycodone. Participants receive either oral SR morphine or oxycodone 2-3 times daily for 4 weeks.

0 / 00 / 0Not reported / Not reported

Group identifiers: EG000: Arm I: Opioid Rotation to Oral Methadone · EG001: Arm II: Opioid Rotation to Another Long-acting Strong Opioid

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

      Complete source fields
      event Groups
      1. description
        Participants are switched from their current opioid medication (oxycodone or morphine) to methadone. Participants receive oral methadone 2-3 times daily for 4 weeks.
        id
        EG000
        other Num Affected
        0
        other Num At Risk
        1
        serious Num Affected
        0
        serious Num At Risk
        1
        title
        Arm I: Opioid Rotation to Oral Methadone
      2. description
        Participants currently receiving oxycodone are switched to sustained-release (SR) morphine. Participants currently receiving morphine are switched to SR oxycodone. Participants receive either oral SR morphine or oxycodone 2-3 times daily for 4 weeks.
        id
        EG001
        other Num Affected
        0
        other Num At Risk
        0
        serious Num Affected
        0
        serious Num At Risk
        0
        title
        Arm II: Opioid Rotation to Another Long-acting Strong Opioid
      frequency Threshold
      5
      time Frame
      9 Months

      Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

      Preserved source evidence · Not medical advice